Alnylam Pharma (ALNY) Reports Phase 1 Trial Results Show Proof of Concept for ALN-TTR01
Go back to Alnylam Pharma (ALNY) Reports Phase 1 Trial Results Show Proof of Concept for ALN-TTR01| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 242.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $242.61 | 52 Week High | $109.10 | |||
| Open | $242.61 | 52 Week Low | $31.38 | |||
| Day High | $242.61 | P/E | N/A | |||
| Day Low | $242.61 | EPS | $-1.45 | |||
| Volume | 168 | |||||
